Table 2.
Cognitive scores at baseline and 1-year follow-up.
| AD | MCI | CTL | ||||
|---|---|---|---|---|---|---|
| Baseline | 1-year | Baseline | 1-year | Baseline | 1-year | |
| WHOLE AddNeuroMed DATASET | ||||||
| MMSE | 20.9 ± 4.8 | – | 27.1 ± 1.7 | – | 29.1 ± 1.2 | – |
| CDR-sum | 6.5 ± 3.3 | – | 1.4 ± 0.9 | – | 0.1 ± 0.2 | – |
| ADAS1 | 6.6 ± 1.5 | – | 5.6 ± 1.2 | – | 3.8 ± 1.5 | – |
| AddNeuroMed LONGITUDINAL DATASET | ||||||
| MMSE | 22.2 ± 4.4 | 21.6 ± 4.9 | 27.2 ± 1.7 | 26.3 ± 2.9 | 29.1 ± 1.2 | 28.8 ± 0.3 |
| CDR-sum | 5.6 ± 3.0 | 7.2 ± 4.0 | 1.6 ± 0.9 | 2.1 ± 1.5 | 0.1 ± 0.2 | 0.1 ± 0.4 |
| ADAS1 | 6.3 ± 1.5 | 6.5 ± 1.8 | 5.5 ± 1.2 | 5.5 ± 1.4 | 3.9 ± 1.6 | 3.7 ± 1.5 |
Data is presented as mean ± standard deviation. AD, Alzheimer disease; MCI, mild cognitive impairment; CTL, healthy control; MMSE, Mini Mental State Examination; CDR-sum, Clinical Dementia Rating sum of boxes; ADAS1, Alzheimer Disease Assessment Scale.